SCHEMBL19265541

SCHEMBL19265541

CCOC(=O)C1=Cc2cc(-c3ccccc3C(C)C)ccc2NC(N=NN)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 2/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33
▸ PPARG P37231 1/20 0.33
▸ ADORA3 P0DMS8 3/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ TRPA1 O75762 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ FFAR1 O14842 3/20 0.31
▸ TRPV1 Q8NER1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19265647 0.88 PRKCZ (0.37) ADORA3ALDH1A1TRPV1
SCHEMBL19265526 0.86 TLR8 (0.40) TLR8TLR7ADORA3CA12CA1
SCHEMBL19265548 0.84 LMNA (0.36) TLR8TLR7ADORA3KDM4EALDH1A1
SCHEMBL19265523 0.84 TLR8 (0.35) TLR8TLR7CA12CA1CA2
SCHEMBL19265638 0.83 KDM4E (0.36) TLR8TLR7CA12CA1CA2
SCHEMBL19265705 0.83 FDFT1 (0.38) TLR8TLR7CA12CA1CA2
SCHEMBL19265644 0.81 MMP2 (0.41) TLR8TLR7ALDH1A1HPGDSMN1; SMN2
SCHEMBL19265650 0.81 KDM4E (0.39) TLR8TLR7KDM4EALDH1A1MAPT
SCHEMBL19265546 0.80 TLR8 (0.33) TLR8TLR7KDM4EALDH1A1MAPT
SCHEMBL19265655 0.77 HPGD (0.35) TLR8TLR7KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3208263-A1 SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS VentiRx Pharmaceuticals, Inc. (US) 2017-08-23 — — EP disclosed
Send feedback